CXCL3 and neoplasm: Since the tumor lesions present at 2 months of age in Ptch1+/-/Tis21-/- mice develop invariably into a MB (Farioli-Vecchioli et al., 2012), these data represent a proof of concept that the treatment with Cxcl3 can reduce MB formation.